The latest closing stock price for Aptevo Therapeutics as of July 22, 2025 is 3.13.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -75.54% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 1000000.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 381.48, which is 12087.9% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 2.81, which is 10.2% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 108.62.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -75.54% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 1000000.00 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 381.48, which is 12087.9% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 2.81, which is 10.2% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 108.62.